v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income $ 92 $ 1,906
Income from discontinued operations, net of tax 0 6,483
Net income (loss) from continuing operations 92 (4,577)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation expense 2,622 2,724
Amortization expense 1,074 459
Amortization of debt issuance costs 150 217
Asset impairments 0 1,622
Deferred income taxes 8 (32)
Reduction of losses on accounts receivable (952) (488)
Non-cash lease expense (77) 85
Stock-based compensation expense 687 512
Changes in operating assets and liabilities:    
Accounts receivable and advances (8,115) (5,210)
Inventories (1,573) (1,450)
Other assets and liabilities (503) (1,517)
Accounts payable 3,088 (1,535)
Accrued expenses (2,085) 1,741
Accrued income taxes 126 (119)
Net cash used in operating activities - continuing operations (5,458) (7,568)
Net cash provided by operating activities - discontinued operations 0 6,783
Net cash used in operating activities (5,458) (785)
Investing activities    
Purchases of property, plant and equipment (2,256) (1,082)
Acquisitions, net of cash acquired (13,600) 0
Net cash used in investing activities - continuing operations (15,856) (1,082)
Net cash provided by investing activities - discontinued operations 0 52,525
Net cash provided by (used in) investing activities (15,856) 51,443
Financing activities    
Borrowings from credit facilities 80,350 114,470
Proceeds from note payable 997 1,085
Proceeds from exercise of stock options 398 0
Payments on credit facilities (80,350) (114,470)
Payments on note payable (832) (696)
Principal payments on finance lease obligations (246) (219)
Repurchase of common stock (6,850) (8,875)
Net cash used in financing activities - continuing operations (6,533) (8,705)
Net cash used in financing activities - discontinued operations 0 (19)
Net cash used in financing activities (6,533) (8,724)
Increase (decrease) in cash, cash equivalents and restricted cash (27,847) 41,934
Cash, cash equivalents and restricted cash at beginning of period 57,606 16,108
Cash, cash equivalents and restricted cash at end of period $ 29,759 $ 58,042